A detailed history of Colony Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Colony Group LLC holds 7,121 shares of NVS stock, worth $701,062. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,121
Previous 7,489 4.91%
Holding current value
$701,062
Previous $756,000 4.1%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $34,860 - $38,687
-368 Reduced 4.91%
7,121 $725,000
Q2 2023

Aug 15, 2023

SELL
$92.52 - $104.91 $7,864 - $8,917
-85 Reduced 1.12%
7,489 $756,000
Q1 2023

May 16, 2023

SELL
$80.03 - $92.81 $113,802 - $131,975
-1,422 Reduced 15.81%
7,574 $697,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $135,612 - $166,073
1,795 Added 24.93%
8,996 $816,000
Q3 2022

Nov 15, 2022

BUY
$74.61 - $87.26 $344,474 - $402,879
4,617 Added 178.68%
7,201 $547,000
Q2 2022

Aug 16, 2022

SELL
$80.52 - $93.75 $383,919 - $447,000
-4,768 Reduced 64.85%
2,584 $218,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $9,452 - $10,693
118 Added 1.63%
7,352 $645,000
Q4 2021

Feb 15, 2022

BUY
$79.7 - $88.13 $159 - $176
2 Added 0.03%
7,234 $633,000
Q3 2021

Nov 17, 2021

SELL
$81.78 - $95.14 $92,084 - $107,127
-1,126 Reduced 13.47%
7,232 $591,000
Q2 2021

Aug 18, 2021

SELL
$85.24 - $94.15 $189,744 - $209,577
-2,226 Reduced 21.03%
8,358 $763,000
Q1 2021

May 21, 2021

BUY
$83.5 - $98.47 $160,737 - $189,554
1,925 Added 22.23%
10,584 $905,000
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $146,225 - $176,867
-1,873 Reduced 17.78%
8,659 $818,000
Q3 2020

Nov 17, 2020

BUY
$82.14 - $91.0 $21,767 - $24,115
265 Added 2.58%
10,532 $916,000
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $28,811 - $32,431
-356 Reduced 3.35%
10,267 $897,000
Q1 2020

May 18, 2020

BUY
$70.67 - $99.01 $105,863 - $148,316
1,498 Added 16.42%
10,623 $876,000
Q4 2019

Feb 18, 2020

SELL
$84.35 - $95.37 $90,929 - $102,808
-1,078 Reduced 10.57%
9,125 $864,000
Q3 2019

Nov 26, 2019

BUY
$85.54 - $94.26 $6,928 - $7,635
81 Added 0.8%
10,203 $887,000
Q2 2019

Aug 19, 2019

BUY
$75.4 - $92.8 $376,396 - $463,257
4,992 Added 97.31%
10,122 $924,000
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $144,765 - $165,580
1,922 Added 59.91%
5,130 $493,000
Q4 2018

Feb 15, 2019

SELL
$73.66 - $82.02 $9,133 - $10,170
-124 Reduced 3.72%
3,208 $275,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $11,714 - $13,550
175 Added 5.54%
3,332 $287,000
Q2 2018

Aug 15, 2018

SELL
$64.91 - $73.36 $7,789 - $8,803
-120 Reduced 3.66%
3,157 $238,000
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $295,567 - $353,345
-4,199 Reduced 56.17%
3,277 $265,000
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $350,294 - $376,010
4,843 Added 183.93%
7,476 $628,000
Q3 2017

Nov 15, 2017

BUY
$74.14 - $77.27 $195,210 - $203,451
2,633
2,633 $226,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.